Business & Profession

Sitting Down With Jim Mazzo, Operating Partner at Versant Ventures.

A student lost sight in one eye after failing to remove her disposable contact lenses for six months. So how did tabloid journalists turn it into such a popular news story?

SIRT1 appears to be an anti-aging protein that protects against weight gain, diabetes, inflammation, and even optic neuritis… in mouse models. Is SIRT1 the key to eternal youth, or simply snake oil?

Is the potential dystopia that is myopia a consequence of too much study?

Dramatic improvements in the results from an astigmatic keratotomy model suggest that the femtosecond laser may be more than a rich ophthalmologist’s toy after all.

Sitting Down With Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

With childhood vision disorders like amblyopia and strabismus, early diagnosis is the key to treatment success.

Big data analytics is the most sophisticated method yet devised for “augmenting the human intellect”.

A head-mounted iPhone-based ophthalmoscope is the latest step in the rapidly evolving world of smartphone fundoscopy

Valeant and Allergan continue to joust, Santen purchases MSD’s ophthalmology drug portfolio in selected markets, and Kala completes a US$22.5 million Series B financing round